Filing Details
- Accession Number:
- 0001104659-22-067241
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-01 18:59:50
- Reporting Period:
- 2022-05-31
- Accepted Time:
- 2022-06-01 18:59:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1012477 | Avadel Pharmaceuticals Plc | AVDL | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1494386 | J Eric Ende | C/O Avadel Pharmaceuticals Plc 10 Earlsfort Terrace Dublin 2 L2 D02 T380 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Adss | Acquisiton | 2022-05-31 | 15,000 | $2.16 | 114,900 | No | 4 | P | Direct | |
| Adss | Acquisiton | 2022-06-01 | 20,000 | $2.27 | 134,900 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.1194 to $2.1799, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.2499 to $2.2999, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Billionaire Hedge Funds
